SCHEMBL12366246

SCHEMBL12366246

[C-]#[N+]c1c(C(F)(F)F)cc(-c2cccc(C)c2)n(Cc2ccccc2C)c1=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 3/20 0.39
ALDH1A1 P00352 4/20 0.36
KDM4E B2RXH2 2/20 0.36
ATM Q13315 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
LMNA P02545 1/20 0.36
RXRA P19793 2/20 0.36
NR1H2 P55055 2/20 0.36
NR1H3 Q13133 2/20 0.36
C5AR1 P21730 4/20 0.35
MDM2 Q00987 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
HTT P42858 1/20 0.34
PTGS2 P35354 2/20 0.33
PTGS1 P23219 1/20 0.33
TP53 P04637 1/20 0.33
AR P10275 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12366461 0.93 CMA1 (0.35) GAARXRANR1H2NR1H3C5AR1
SCHEMBL12366281 0.93 MDM2 (0.40) GAAALDH1A1KDM4EATMNPSR1
SCHEMBL12366463 0.92 RXRA (0.36) ALDH1A1KDM4ELMNARXRANR1H2
SCHEMBL12366323 0.92 NR1H2 (0.39) GAARXRANR1H2NR1H3MDM2
SCHEMBL12366218 0.92 ALDH1A1 (0.41) GAAALDH1A1KDM4EATMNPSR1
SCHEMBL12366328 0.91 NR1H2 (0.41) ALDH1A1KDM4ELMNARXRANR1H2
SCHEMBL12366339 0.90 ALDH1A1 (0.42) ALDH1A1KDM4ELMNARXRANR1H2
SCHEMBL12366467 0.90 RXRA (0.37) RXRANR1H2NR1H3C5AR1MDM2
SCHEMBL12366504 0.89 MCL1 (0.37) GAAALDH1A1NPSR1RXRANR1H2
SCHEMBL12366413 0.88 NR1H2 (0.36) ALDH1A1KDM4ENPSR1LMNARXRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7998986-B2 Heterocyclic compounds, in particular N-substituted pyridones for modulating the activity of nuclear receptors EXELIXIS PATENT COMPANY LLC (US) 2011-08-16 US disclosed